Skip to main content

Month: August 2024

Vilvi Group starts construction of €50 million cheese production facility in Latvia

With the laying of a symbolic capsule, Vilvi Group, one of the biggest dairy enterprises in the Baltic States, began building of a new cheese factory in Bauska, Latvia. The facility is the biggest investment project in the Group’s history, with a value of over EUR 50 million. Additional production capacity of more than 8,000 square metres will be built on the territory of Baltic Dairy Board SIA, the dairy processing plant owned by Vilvi Group. The project is financed with own funds and Citadele Bank loans. The Latvian Government, through the Latvian State Development Finance Institution ALTUM, will contribute more than EUR 8.5 million to the project. “The factory’s construction will be completed in 2026. It will be equipped with an automated, robotic and state-of-the-art cheese production facility, creating more than 100 new...

Continue reading

Correction: On track with Growth Plan – EBT margin of 24-30% is maintained

  cBrain (NASDAQ: CBRAIN) corrects the announcement released this morning: The Interim Report incorrect guides an EBT margin of 20-25 % for 2024. cBrain maintains the guidance for the fiscal year 2024 with earnings before tax margin (EBT margin) of 24-30%. This is based on continued growth in Denmark, increased international sales, and increased investments into the growth plan in the second half of 2024. Best regards Per Tejs Knudsen, CEO ——-   Company Announcement no. 09/2024 On track with Growth Plan   Copenhagen, August 21, 2024   Revenue grew by +6% to DKK 139m in the first half of 2024, up from DKK 132m in the first half of 2023. The low half-year growth was expected due to an unusual revenue split between the first and second half of 2023, where first-half revenue grew +39% year over year and accounted for 55% of the...

Continue reading

On track with Growth Plan

Company Announcement no. 09/2024 On track with Growth PlanCopenhagen, August 21, 2024Revenue grew by +6% to DKK 139m in the first half of 2024, up from DKK 132m in the first half of 2023. The low half-year growth was expected due to an unusual revenue split between the first and second half of 2023, where first-half revenue grew +39% year over year and accounted for 55% of the total fiscal year revenue. Danish revenue grew by +21% to DKK 87m in the first half of 2024, up from DKK 72m in the first half of 2023, showing a stable and solid development in the Danish market. International sales declined by -13% to DKK 52m in the first half of 2024, down from DKK 60m in the first half of 2023. The lower international sales are due to the unusual revenue split between the first and second half of 2023, where a large portion of total software...

Continue reading

TDC NET Holding Financial Report First Half 2024

August 2024 TDC NET Holding Semi-Annual Results Report 2024 TDC NET Holding has released the results of the first half year of 2024. The report highlights the TDC NET Holding accomplishments and financial performance during this period, showcasing our dedication to empower green digital connections. Click here to access the full report. TDC tickers Reuters TDC.CO. Bloomberg TDC DC. For any inquiries related to the above, kindly reach out to TDC NET using the contact details provided below. For investor enquiries: Henrik Hjortshøj-Nielsen, phone: +45 21 29 89 91 e-mail: henhjo@tdcnet.dk Press contact: Lasse Bjerre Sørensen, phone: +45 29 29 23 33 e-mail: lasso@tdcnet.dkAttachmentTDC NET Holding Press Release H1 2024 – Final

Continue reading

Sydbank’s Interim Report – First Half 2024

Company Announcement No 38/202421 August 2024 Sydbank’s Interim Report – First Half 2024 H1 2024 – highlightsProfit for the period of DKK 1,624m equals a return on equity of 22.4% p.a. after tax Core income of DKK 3,646m is 8% higher compared to the same period in 2023 Trading income of DKK 153m compared to DKK 186m in the same period in 2023 Costs (core earnings) of DKK 1,659m compared to DKK 1,600m in the same period in 2023 Core earnings before impairment of DKK 2,140m are 8% higher compared to the same period in 2023 Impairment charges for loans and advances etc represent an expense of DKK 24m Bank loans and advances have risen by DKK 4.7bn, equal to an increase of 6% compared to year-end 2023 The CET1 ratio stands at 17.7%, equal to a decrease of 1.2pp compared to year-end 2023CEO Mark Luscombe comments on the result:It is...

Continue reading

Perseus Mining Sells Shares in Montage Gold Corp

Perth, Aug. 21, 2024 (GLOBE NEWSWIRE) —         Perth, Western Australia/ August 21, 2024/Perseus Mining Limited (ASX/TSX:PRU) (Perseus or the Company) is pleased to announce that on August 20, 2024, the Company entered into an agreement with BMO Nesbitt Burns Inc. (BMO), pursuant to which Perseus agreed to sell 33,000,000 common shares (Common Shares) in the capital of TSX-V listed gold explorer and aspiring developer Montage Gold Corp. (Montage) (CVE:MAU) to BMO at a price of C$1.86 per Common Share (the Montage Share Sale). The Montage Share Sale was executed by way of a bought deal to realise net proceeds of C$61.38 million (US$45.0 million). Perseus acquired the shares in Montage when it acquired Orca Gold Inc. (Orca) in May 2022. Orca’s principal asset was a 70% interest in the Block 14 Gold Project (since renamed Meyas...

Continue reading

TCM Group A/S: Interim report Q2 2024

COMPANY ANNOUNCEMENT No. 194/2024         Tvis, 21 August 2024 Interim report Q2 2024 (April 1 – June 30) (All figures in brackets refer to the corresponding period in 2023 – AUBO Production A/S is incl.in the figures as from 3 July 2023) Organic growth in sales and improved earnings, despite challenging market conditions. CEO Torben Paulin:“Sales in the second quarter have developed positively despite the, as expected, weak B2B-kitchen market. Organically sales grew by 5% year-on-year supported by a growth in B2C sales of more than 25% y-o-y. As expected B2B sales declined in the quarter due to the slowdown in the Project sales market. Overall revenue in Q2 was DKK 332 million compared to DKK 256 million in Q2 last year. Sales in Denmark, which accounts for 80% of the Group revenue, increased by 15%, with an underlying organic...

Continue reading

Ultimovacs ASA Reports Second Quarter 2024 Financial Results and Provides General Business Update

Oslo, August 21, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces its second quarter 2024 results today. Conference call and webcast scheduled for August 21, 2024, at 14:00 (CET). Link to webcast here. Second Quarter 2024 Business UpdateFollowing the negative INITIUM result in March 2024, Ultimovacs implemented cash preservation initiatives during the second quarter of 2024 extending the anticipated cash runway to the fourth quarter of 2025, beyond the topline readout of the FOCUS trial and the anticipated topline readout of the DOVACC trial. In August 2024, Ultimovacs reported topline results from the Phase II FOCUS trial in head and neck cancer. The trial did not meet the primary endpoint of improved progression-free survival...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.